“…Although the underlying mechanisms are still unclear, both leptin and its receptor expression and function have been positively correlated with cancer progression in some endocrine-related cancers [ 137 ] and this effect seems to be mainly mediated by LEPR activation of PI3K, ERK1/2 and Jak2/Stat3 signaling pathways [ 138 , 139 , 140 , 141 ]. These pathways regulate the expression of several cancers related genes such as cyclin D1, COX-2, VEGF and potentiates several procarcinogenic processes including angiogenesis, antiapoptosis, cell proliferation, migration and mesenchymal transformation [ 142 , 143 , 144 ]. This contributes to various steps of tumor progression, from cancer stem cell activity, survival, growth and proliferation to metastatic invasion in different types of cancer cells [ 145 , 146 , 147 , 148 , 149 , 150 ].…”